CN104225508A - 一种治疗颈椎病的中药组合物及其制备方法 - Google Patents
一种治疗颈椎病的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN104225508A CN104225508A CN201410563752.9A CN201410563752A CN104225508A CN 104225508 A CN104225508 A CN 104225508A CN 201410563752 A CN201410563752 A CN 201410563752A CN 104225508 A CN104225508 A CN 104225508A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- cervical spondylosis
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 206010041591 Spinal osteoarthritis Diseases 0.000 title claims abstract description 27
- 208000036319 cervical spondylosis Diseases 0.000 title claims abstract description 26
- 208000005801 spondylosis Diseases 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims description 11
- 241000903946 Clematidis Species 0.000 claims abstract description 18
- 241000628997 Flos Species 0.000 claims abstract description 16
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 44
- 239000008280 blood Substances 0.000 abstract description 44
- 230000001737 promoting effect Effects 0.000 abstract description 32
- 230000017531 blood circulation Effects 0.000 abstract description 24
- 210000003205 muscle Anatomy 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 16
- 210000002435 tendon Anatomy 0.000 abstract description 13
- 230000004087 circulation Effects 0.000 abstract description 12
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 230000002040 relaxant effect Effects 0.000 abstract description 9
- 210000000988 bone and bone Anatomy 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 4
- 241000218671 Ephedra Species 0.000 abstract description 3
- 235000006533 astragalus Nutrition 0.000 abstract description 3
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 2
- 241000501743 Gentiana macrophylla Species 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 244000046146 Pueraria lobata Species 0.000 abstract description 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 32
- 208000002193 Pain Diseases 0.000 description 20
- 230000036407 pain Effects 0.000 description 20
- 239000000796 flavoring agent Substances 0.000 description 17
- 235000019634 flavors Nutrition 0.000 description 17
- 229940079593 drug Drugs 0.000 description 16
- 208000006820 Arthralgia Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000003414 extremity Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000013219 diaphoresis Diseases 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 235000021251 pulses Nutrition 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000007613 Shoulder Pain Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 235000021374 legumes Nutrition 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010005963 Bone formation increased Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000725146 Clematis hexapetala Species 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000967672 Gentiana crassicaulis Species 0.000 description 2
- 241000501719 Gentiana straminea Species 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 201000004484 acute conjunctivitis Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 208000019804 backache Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000002385 vertebral artery Anatomy 0.000 description 2
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000510654 Bupleurum chinense Species 0.000 description 1
- 241000213015 Bupleurum scorzonerifolium Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 206010064012 Central pain syndrome Diseases 0.000 description 1
- 206010008334 Cervicobrachial syndrome Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- 241001256368 Clematis chinensis Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 244000241463 Cullen corylifolium Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 241000963421 Curcuma kwangsiensis Species 0.000 description 1
- 235000003397 Curcuma kwangsiensis Nutrition 0.000 description 1
- 240000005629 Curcuma phaeocaulis Species 0.000 description 1
- 235000003391 Curcuma phaeocaulis Nutrition 0.000 description 1
- 241000963390 Curcuma wenyujin Species 0.000 description 1
- 235000003394 Curcuma wenyujin Nutrition 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 241000514824 Cyathula officinalis Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000723281 Ephedra equisetina Species 0.000 description 1
- 241000218670 Ephedraceae Species 0.000 description 1
- 241000290619 Gentiana dahurica Species 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 241000931143 Gleditsia sinensis Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241000382951 Hansenia forbesii Species 0.000 description 1
- 241000533388 Hansenia weberbaueriana Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010051326 Ligament calcification Diseases 0.000 description 1
- 241000927897 Lycopodium japonicum Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000800405 Spatholobus suberectus Species 0.000 description 1
- 208000021945 Tendon injury Diseases 0.000 description 1
- 244000105017 Vicia sativa Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000003461 brachial plexus Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗颈椎病的中药组合物,它是由柴胡、郁金、丹参、威灵仙、桂枝、红花、葛根、麻黄、黄芪、羌活、鸡血藤、秦艽、川牛膝、伸筋草、补骨脂、皂角刺、生甘草按照一定的重量配比组成,具有活血化瘀,行气通络,舒筋活血,祛风散寒,养血和血,补肝益肾,强筋壮骨的功效,能够有效治疗颈椎病。
Description
技术领域
本发明涉及一种中药组合物,具体涉及一种治疗颈椎病的中药组合物,本发明还涉及该中药制剂的制备方法。
背景技术
颈椎病又称颈椎综合征,是颈椎骨关节炎、增生性颈椎炎、颈神经根综合征、颈椎间盘脱出症的总称。是一种以退行性病理改变为基础的疾患。主要由于颈椎长期劳损、骨质增生,或椎间盘脱出、韧带增厚,致使颈椎脊髓、神经根或椎动脉受压,出现一系列功能障碍的临床综合征。表现为颈椎间盘退变本身及其继发性的一系列病理改变,如椎节失稳、松动;髓核突出或脱出;骨刺形成;韧带肥厚和继发的椎管狭窄等,刺激或压迫了邻近的神经根、脊髓、椎动脉及颈部交感神经等组织,并引起各种各样症状和体征的综合征。
颈椎病临床表现复杂多样,患者多以头晕、颈强、项背沉困疼痛、肩臂手指麻木或放射样痛。中医学关于颈椎病的论述,散见于“眩晕”、“痹症”、“痉症”、“萎症”、“头痛”、“项强”、“颈筋急”、“颈肩痛”等,其病机为肝脾肾渐虚、气血不足、营卫失和、血行瘀滞、筋骨失养,加之积劳伤筋,或感受风寒湿邪,致风、痰、瘀互结,脉络瘀滞,经气不利而变生诸症,其肝肾不足为本,风痰瘀为标。中药在治疗颈椎病方面的效果十分显著,中药对颈椎病的治疗是整体性的,而西医手术等只是针对病变部位进行治疗。中药通过内含特殊药物成分作用于颈椎病的各个病理层面,整体改善颈椎病的各种病理变化来达到治疗颈椎病的目的,而且中药治疗颈椎病无西医手术等存在损伤,使用方便安全,临床疗效显著,副作用较小。
发明内容
本发明的目的是提供一种中药组合物,该中药组合物对于治疗颈椎病具有疗效确切,副作用小,服用方便,价格低廉的特点。减轻了患者的病痛,提高患者的生活质量。
本发明选择柴胡、郁金、丹参、威灵仙、桂枝、红花、葛根、麻黄、黄芪、羌活、鸡血藤、秦艽、川牛膝、伸筋草、补骨脂、皂角刺、生甘草进行组合,将这些药物组合使得各药物功效产生协同作用,使之具有活血化瘀,行气通络,舒筋活血,祛风散寒,养血和血,补肝益肾,强筋壮骨的功效,从而能够有效治疗颈椎病。
本发明中药物的作用:
其中:
柴胡:为伞形科多年生草本植物柴胡Bupleurum chinense DC.(北柴胡)或狭叶柴胡Bupleurum scorzonerifolium Willd.(南柴胡)的根或全草。性味:苦、辛、微寒。归肝、肺、脾经。功效:疏肝解郁,升举阳气。
郁金:为姜科植物温郁金Curcuma wenyujin Y. H. Chen et C. Ling、姜黄Curcuma longa L.、广西莪术Curcuma kwangsiensis S. G. Lee et C. F. Liang或蓬莪术Curcuma phaeocaulis Val.的干燥块根。性味:辛、苦,寒。归肝、心、肺经。功效:活血止痛,行气解郁,清心凉血,利胆退黄。郁金辛开苦降,芳香宣达,性寒又能清热。既入气分以行气解郁,又入血分以凉血祛瘀,为血中之气药,用于治疗气血郁滞的胸痛。《日华子本草》:养神定志,通利关脉。治冷热劳,骨节疼痛,四肢不遂;排脓止痛,生肌长肉;破宿血,补新生血;安生胎,落死胎;止血崩带下,调妇人经脉不匀,血邪心烦;恶疮疥癣,瘿赘肿毒,丹毒;头痛,赤眼,热温狂闷。
丹参:为双子叶植物唇形科 Labiatae鼠尾草属植物丹参 Salvia miltiorrhiza Bge. 的干燥根及根茎。性味苦,微寒。入心、肝经。功效:活血调经,祛瘀止痛,凉血消痈,清心除烦,养血安神。《日华子本草》:养神定志,通利关脉。治冷热劳,骨节疼痛,四肢不遂;排脓止痛,生肌长肉;破宿血,补新生血;安生胎,落死胎;止血崩带下,调妇人经脉不匀,血邪心烦;恶疮疥癣,瘿赘肿毒,丹毒;头痛,赤眼,热温狂闷。
威灵仙:为双子叶植物毛茛科Ranunculaceae 威灵仙Clematis chinensisOsbeck 、棉团铁线莲(山蓼)C.hexapetala Pall.或东北铁线莲(黑薇)C. manshuricaRupr.的干燥根及根茎。性味辛、咸,温,有毒。入膀胱经。功效:祛风除湿,通络止痛,消痰水,散癖积。用于风湿痹痛、肢体麻木、屈伸不利。凡风湿痹痛、麻木不仁,无论上下皆可用,为风湿痹痛要药,《药品化义》中云:灵仙,性猛急,善走而不守,宣通十二经络。主治风、湿、痰壅滞经络中,致成痛风走经,骨节疼痛,或肿,或麻木。
桂枝:为樟科植物肉桂 Cinnamomum cassia Presl的干燥嫩枝。性味辛、甘,温。归膀胱、心、肺经。功效:发汗解肌,温经通脉,助阳化气,散寒止痛。桂枝性温,善通阳气,能化阴寒,对阴寒遏阻阳气,津液不能输布,因而水湿停滞形成痰饮的病症。
红花:为菊科植物红花Carthamus tinctorius L.的筒状花冠。性味辛、温。归心、肝经。功效:活血通经、散瘀止痛。红花有扩张血管作用。红花黄色素可明显延长血浆复钙时间、凝血酶原时间和凝血时间。《本草衍义补遗》:红花,破留血,养血。多用则破血,少用则养血。
葛根:为豆科植物野葛 Pueraria lobata (Willd.)Ohwi 的干燥根。性味凉,甘、辛。入脾、胃经。功效:发表解肌,透发麻疹,解热生津,升阳止泻。葛根配伍麻黄、桂枝:葛根善于缓解项背肌肉痉挛 为表证兼项背强急之要药;麻黄、桂枝有发散风寒之功效.三者合用 共奏散寒解表、缓急止痛之功效 多用于治疗项背强痛者。
麻黄:为麻黄科植物草麻黄Ephedra sinicaStapf,中麻黄Ephedra intermediaSchrenk et C. A. Mey. 或木贼麻黄Ephedra equisetinaBge. 的草质茎。性味辛、微苦,温。归肺、膀胱经。功效:发汗散寒,宣肺平喘,利水消肿。麻黄碱能提高中枢性痛觉阈值, 产生镇痛作用。
黄芪:为豆科植物蒙古黄芪 Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.)Hsiao 或膜荚黄芪 Astragalus membranaceus (Fisch.) Bge.的干燥根。性味:甘,微温。归肺、脾、肝、肾经。功效:补气升阳、固表敛汗、利水消肿、托疮排脓、通调水道。
羌活:为伞形科植物羌活(背翅芹)Notopterygium incisum Ting ex H. T. Chang 或宽叶羌活Notopterygium forbesii Boiss. 的干燥根茎及根。性味:辛、苦,温。归膀胱、肾经。功效:散寒,祛风,除湿,止痛。用于风寒感冒头痛,风湿痹痛,肩背酸痛。羌活辛温,气雄而散,既能解表,又能胜湿止痛,辛散祛风,味苦燥湿,性温散寒,能祛风寒湿邪,又轻体上达,故善治上半身风寒湿痹。可配防风、独活等同用。
鸡血藤:为豆科 Leguminosae 植物密花豆 Spatholobus suberectusDunn 的干燥藤茎。性味苦、甘,温。归肝、肾经。功效:补血,活血,通络。本品行血养血,舒筋活络,为治疗经脉不畅,络脉不和病证的常用药。
秦艽:为龙胆科植物秦艽Gentiana macrophylla Pall. 、麻花秦艽Gentiana straminea Maxim. 、粗茎秦艽Gentiana crassicaulis Duthie ex Burk.或小秦艽Gentiana dahurica Fisch. 的干燥根。性味辛、苦,微寒。归胃经、肝经、胆经。功效:袪风湿,舒筋络,清虚热。威灵仙和秦艽配伍,威灵仙祛风湿、通经络;秦艽辛散苦泄,性质和平,为风中之润剂,能散风除湿、舒筋通络,偏治下半身疼痛,两药配伍,治慢性风湿性关节炎、关节疼痛、屈伸不利、手足麻木。
川牛膝:为苋科植物川牛膝 Cyathula officinalis Kuan 的干燥根。性味:甘、微苦,平。归肝、肾经。功效:逐瘀通经,通利关节,利尿通淋。《中药志》:破血下降。
伸筋草:为石松科石松属植物石松Lycopodium japonicum Thunb.的全草。性味苦、辛,温。入肝经。功效:祛风散寒,除湿消肿,舒筋活络。用于风寒湿痹,筋脉拘挛疼痈。
补骨脂:为豆科植物补骨脂 Psoralea corylifolia L. 的干燥成熟果实。性味辛、苦;温。归肾、心包、脾、胃、肺经。功效:补肾助阳;纳气平喘;温脾止泻。
皂角刺:为豆科植物皂荚Gleditsia sinensis Lam. 的干燥棘刺。性味:辛,温。归肺、肝经。功效:消肿排脓,活血祛风。
生甘草:为豆科植物甘草 Glycyrrhiza uralensis Fisch.,胀果甘草 Glycyrrhiza Inflata Bat.或光果甘草Glycyrrhiza Glabra L.的干燥根及根茎。性味甘,平。归心、肺、脾、胃经。功效:补脾和胃,益气复脉。
本发明的方解是:方中柴胡疏肝解郁、升举阳气,郁金活血止痛,行气解郁,丹参活血调经、祛瘀止痛,威灵仙通络止痛,以上四味共奏活血、舒筋、行气、止痛之功,从疾病的根本上疏通经络、活血祛瘀,行气解郁,病灶部位没有气血均没有瘀阻疼痛方可痊愈,桂枝助君药威灵仙温经通脉,助阳化气,红花助丹参活血通经、散瘀止痛,葛根、麻黄发汗解肌升阳止泻,黄芪益气固表,羌活祛散风湿,以上六味共为臣药,不仅可以助君药活血化瘀、行气通络,强筋壮骨,而且可以祛除病灶处的风寒、风湿,是颈椎病得到更好的治疗。鸡血藤补血活血通络,秦艽祛风湿、通经络,川牛膝逐瘀通经,伸筋草祛风散寒,补骨脂补肾壮阳,皂角刺活血祛风,以上六味共为佐药,以辅助药物行气通络,舒筋活血,祛风散寒。生甘草调和诸药,引药归经,为使药。此方诸药合用,君臣协力,佐使共辅,具有活血化瘀,行气通络,舒筋活血,祛风散寒,养血和血,补肝益肾,强筋壮骨的功效,能够有效治疗颈椎病。
本发明药物原料用量是经发明人进行大量摸索总结得出的,各原料用量为在下述重量份范围都具有较好的疗效:柴胡7-17份、郁金10-20份、丹参19-29份、威灵仙15-25份、桂枝13-23份、红花5-15份、葛根10-20份、麻黄3-9份、黄芪45-55份、羌活15-25份、鸡血藤19-29份、秦艽10-20份、川牛膝10-20份、伸筋草15-25份、补骨脂15-25份、皂角刺15-25份、生甘草4-14份。
其中优选为:柴胡12份、郁金15份、丹参24份、威灵仙20份、桂枝18份、红花10份、葛根15份、麻黄6份、黄芪50份、羌活20份、鸡血藤24份、秦艽15份、川牛膝15份、伸筋草20份、补骨脂20份、皂角刺20份、生甘草9份。
本发明药物可以采用中药制剂的常规制备工艺,可制成任何一种药剂学上所说的剂型,如丸剂、散剂、片剂、胶囊剂、颗粒剂、糖浆剂、口服液等。例如可以将这些原料药研成粉末状混合均匀制成散剂冲服;可以用水煎,经过滤得滤液,加入防腐剂制成口服液;必要时也可以直接服用汤剂。
一种治疗颈椎病的中药汤剂的制备方法如下:
步骤一:按本发明重量配比,称取郁金、丹参、威灵仙、葛根、黄芪、羌活、秦艽、川牛膝、皂角刺放入非铁质容器中,加入8倍体积的水,先用武火将水煎开,然后转为文火,煎煮1小时,过滤得滤液,备用;
步骤二:将步骤一种的药渣中加入4倍量的水,然后将柴胡、桂枝、麻黄、鸡血藤、伸筋草、以及包好的补骨脂放入锅中文火煎煮0.5小时,最后15分钟左右时加入红花、生甘草,过滤得滤液,合并两次滤液,既得本发明所述中药汤剂。
本发明药物具有活血化瘀,行气通络,舒筋活血,祛风散寒,养血和血,补肝益肾,强筋壮骨等功效,且疗效确切,副作用小,服用方便,价格低廉,据对临床300例患者观察统计,使用本发明具体实施例药物一个疗程总有效率80%,两个疗程总有效率92%。
具体实施方式
实施例一、柴胡7份、郁金10份、丹参19份、威灵仙15份、桂枝13份、红花5份、葛根10份、麻黄3份、黄芪45份、羌活15份、鸡血藤19份、秦艽10份、川牛膝10份、伸筋草15份、补骨脂15份、皂角刺15份、生甘草4份。
实施例二、柴胡12份、郁金15份、丹参24份、威灵仙20份、桂枝18份、红花10份、葛根15份、麻黄6份、黄芪50份、羌活20份、鸡血藤24份、秦艽15份、川牛膝15份、伸筋草20份、补骨脂20份、皂角刺20份、生甘草9份。
实施例三、柴胡17份、郁金20份、丹参29份、威灵仙25份、桂枝23份、红花15份、葛根20份、麻黄9份、黄芪55份、羌活25份、鸡血藤29份、秦艽20份、川牛膝20份、伸筋草25份、补骨脂25份、皂角刺25份、生甘草14份。
下面是患者使用本发明药物的临床统计资料:
一、一般资料
收治患者共300例,平均年龄46岁。
二、中医诊断标准
1、有慢性劳损或外伤史。或有颈椎先天性畸形、颈椎退行性病变。
2、多发于40岁以上中年人,长期低头工作者或习惯于长时间看电视、录相者,往往呈慢性发病。
3、颈、肩背疼痛,头痛头晕,颈部板硬,上肢麻木。
4、颈部活动功能受限,病变颈椎棘突,患侧肩胛骨内上角常有压痛,可摸到条索状硬结,可有上肢肌力减弱和肌肉萎缩,臂丛牵拉试验阳性。压头试验阳性。
5、X线正位摄片显示,钩椎关节增生,张口位可有凿状突偏歪,侧位摄片显示颈椎曲度变直,椎间隙变窄,有骨质增生或韧带钙化,斜位摄片可见椎间孔变小。CT及磁共振检查对定性定位诊断有意义。
三、治疗方法
按照本发明具体实施例药物重量配比,称取原料药(一日剂量),水煎后过滤去渣,早晚各服一次,温服。30天为一个疗程。
四、疗效评定标准
治愈:原有各型病症消失,肌力正常,颈、肢体功能恢复正常,能参加正常劳动和工作。
好转:原有各型症状减轻,颈、肩背疼痛减轻,颈、肢体功能改善。
未愈:症状无改善。
五、治疗结果统计
其中:总有效率=治愈率+好转率。
典型病例及疗效:
病例一、李某,男,65岁,长期靠卧沙发看电视,导致枕颈部痛,颈活动受限,颈肌僵硬,有相应压痛点。X线片示:颈椎生理弧度在病变节段改变,自述每次都感觉眩晕头痛,恶心呕吐,下肢体麻木。检查舌红少津,脉弦。患者服用本发明中药实施例一,一个疗程后病症消失,肌力正常,颈、肢体功能恢复正常,治愈。
病例二、吴某,女,43岁,由于长期伏案工作导致颈肩部刺痛,痛处固定,并伴有肢体麻木。检查舌质暗,脉弦。患者服用本发明中药实施例二,两个疗程后,颈肩部疼痛消失,肢体麻木消失,治愈。
病例三、刘某,男,56岁,自述颈肩、右臂疼痛难忍,头晕目眩,面色苍白,心悸气短,四肢麻木,倦怠乏力。检查舌淡苔少,脉细弱。患者服用本发明中药实施例三,两个疗程后,颈、肩疼痛减轻,好转。
Claims (4)
1.一种治疗颈椎病的中药组合物,其特征在于,该中药组合物是由以下重量份的药物组成:柴胡7-17份、郁金10-20份、丹参19-29份、威灵仙15-25份、桂枝13-23份、红花5-15份、葛根10-20份、麻黄3-9份、黄芪45-55份、羌活15-25份、鸡血藤19-29份、秦艽10-20份、川牛膝10-20份、伸筋草15-25份、补骨脂15-25份、皂角刺15-25份、生甘草4-14份。
2.根据权利要求书1所述的治疗颈椎病的中药组合物,其特征在于,由以下重量份的药物组成:柴胡12份、郁金15份、丹参24份、威灵仙20份、桂枝18份、红花10份、葛根15份、麻黄6份、黄芪50份、羌活20份、鸡血藤24份、秦艽15份、川牛膝15份、伸筋草20份、补骨脂20份、皂角刺20份、生甘草9份。
3.根据权利要求1或2所述的一种治疗颈椎病的中药制剂,其特征在于:所述中药制剂为汤剂。
4.一种治疗颈椎病的中药制剂的制备方法,其特征在于,制备方法如下:步骤一:按本发明重量配比,称取郁金、丹参、威灵仙、葛根、黄芪、羌活、秦艽、川牛膝、皂角刺放入非铁质容器中,加入8倍体积的水,先用武火将水煎开,然后转为文火,煎煮1小时,过滤得滤液,备用;步骤二:将步骤一中的药渣中加入4倍量的水,然后将柴胡、桂枝、麻黄、鸡血藤、伸筋草、以及包好的补骨脂放入锅中文火煎煮0.5小时,最后15分钟左右时加入红花、生甘草,过滤得滤液,合并两次滤液,既得本发明所述中药汤剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410563752.9A CN104225508B (zh) | 2014-10-22 | 2014-10-22 | 一种治疗颈椎病的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410563752.9A CN104225508B (zh) | 2014-10-22 | 2014-10-22 | 一种治疗颈椎病的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104225508A true CN104225508A (zh) | 2014-12-24 |
CN104225508B CN104225508B (zh) | 2017-05-03 |
Family
ID=52214984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410563752.9A Expired - Fee Related CN104225508B (zh) | 2014-10-22 | 2014-10-22 | 一种治疗颈椎病的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104225508B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104667186A (zh) * | 2015-03-06 | 2015-06-03 | 济南骄泰信息技术有限公司 | 一种治疗颈椎病的中药带 |
CN106361927A (zh) * | 2016-09-20 | 2017-02-01 | 陈亚平 | 一种用于治疗颈椎病的中药组合物及其制备方法 |
CN107496836A (zh) * | 2017-09-09 | 2017-12-22 | 成都兴倍加生物科技有限责任公司 | 一种治疗颈椎病的内服药物及其制备方法 |
CN108815328A (zh) * | 2018-09-21 | 2018-11-16 | 武汉新国峰科技开发有限公司 | 一种防治肩颈病的秦艽合剂 |
CN110507742A (zh) * | 2019-09-17 | 2019-11-29 | 吴方保 | 一种治疗颈椎的纯中药药酒糊 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1895622A (zh) * | 2006-06-15 | 2007-01-17 | 游贵平 | 治疗颈椎病的药物 |
CN101757148A (zh) * | 2008-12-24 | 2010-06-30 | 天津市中宝制药有限公司 | 一种治疗颈椎病的中药组合物 |
-
2014
- 2014-10-22 CN CN201410563752.9A patent/CN104225508B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1895622A (zh) * | 2006-06-15 | 2007-01-17 | 游贵平 | 治疗颈椎病的药物 |
CN101757148A (zh) * | 2008-12-24 | 2010-06-30 | 天津市中宝制药有限公司 | 一种治疗颈椎病的中药组合物 |
Non-Patent Citations (2)
Title |
---|
王万骥等: "自拟颈痹汤治疗颈椎病100例", 《实用中医药杂志》 * |
缪卫华等: "汪荫华治疗颈椎病的经验与特色", 《江苏中医药》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104667186A (zh) * | 2015-03-06 | 2015-06-03 | 济南骄泰信息技术有限公司 | 一种治疗颈椎病的中药带 |
CN106361927A (zh) * | 2016-09-20 | 2017-02-01 | 陈亚平 | 一种用于治疗颈椎病的中药组合物及其制备方法 |
CN107496836A (zh) * | 2017-09-09 | 2017-12-22 | 成都兴倍加生物科技有限责任公司 | 一种治疗颈椎病的内服药物及其制备方法 |
CN108815328A (zh) * | 2018-09-21 | 2018-11-16 | 武汉新国峰科技开发有限公司 | 一种防治肩颈病的秦艽合剂 |
CN110507742A (zh) * | 2019-09-17 | 2019-11-29 | 吴方保 | 一种治疗颈椎的纯中药药酒糊 |
Also Published As
Publication number | Publication date |
---|---|
CN104225508B (zh) | 2017-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104689012A (zh) | 一种补肾壮骨酒及其制备方法 | |
CN101766775A (zh) | 一种治疗腰椎间盘突出、骨质增生的药物 | |
CN104225508B (zh) | 一种治疗颈椎病的中药组合物及其制备方法 | |
CN103316141B (zh) | 一种治疗颈椎病的中药组合物 | |
CN103110762A (zh) | 一种治疗骨折久不愈合的中药组合物 | |
CN104306540B (zh) | 一种治疗脑瘤术后肢体麻木的中药制剂及其制备方法 | |
CN104324340B (zh) | 一种治疗跟骨骨质增生的中药制剂及其制备方法 | |
CN101647878B (zh) | 用于治疗风湿麻木的中药制剂 | |
CN100594033C (zh) | 一种内服治疗神经根型颈椎病的中药组合物 | |
CN103599404B (zh) | 一种治疗颈椎病的中药汤剂 | |
CN104258366A (zh) | 一种用于腰痛的中药制剂及其制备方法 | |
CN106344894A (zh) | 一种治疗颈椎病及骨关节疾病的丸剂药物及其制备方法 | |
CN104825993A (zh) | 一种用于跟腱断裂修补术后护理的中药制剂及制备方法 | |
CN105055918A (zh) | 治疗骨病的中药及其制备方法 | |
CN104721644A (zh) | 一种用于膝关节骨性关节炎的中药制剂及其制备方法 | |
CN103800840A (zh) | 一种治疗颈椎病的中药口服液 | |
CN102579672A (zh) | 一种治疗骨质增生和腰椎间盘突出的药物 | |
CN107582989A (zh) | 一种引经健骨、舒筋活络的中药组合物及其制备方法 | |
CN102349986B (zh) | 一种治疗更年期综合症的中药 | |
CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
CN104398975A (zh) | 一种治疗乳腺纤维瘤的中药制剂及其制备方法 | |
CN104958677A (zh) | 一种治疗膜性肾病的中药制剂及其制备方法 | |
CN104721802A (zh) | 一种治疗缩窄性心包炎的中药制剂及其制备方法 | |
CN104547553A (zh) | 一种治疗神经性内分泌紊乱的中药 | |
CN103463397A (zh) | 一种治疗肾阴虚的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170503 Termination date: 20171022 |